Gossamer Bio Inc (NASDAQ:GOSS)
| 14.99 Delayed Data As of 4:00pm ET |  +0.29 / +1.97%Today’s Change | 13.12 Today|||52-Week Range 27.15 | -4.09% Year-to-Date |
Latest GOSS News | Press Releases
No recent news for Gossamer Bio Inc.
Today’s Trading
| Previous close | 14.70 |
| Today’s open | 14.71 |
| Day’s range | 14.45 - 15.04 |
| Volume | 221,716 |
| Average volume (3 months) | 544,996 |
| Market cap | $960.9M |
Data as of 4:00pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | -2,070.23% |
| Earnings growth (this year) | +86.15% |
| Earnings growth (next 5 years) | +34.42% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | March 20, 2020 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$147.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
